Table 1: Clinical course and laboratory data of the patient during hospitalization.
Laboratory data (normal limits) | Oct 31 | Nov 3 | Nov 6 | Nov 9 | Nov 16 | Nov 20 | Nov 25 | Nov 30 | Dec 3 | Dec 10 |
Admission | Ward | Ward | Ward | ICU | ICU | ICU | ICU | ICU | ICU | ICU |
Temperature (peak, ℃) | 39.2 | 40.4 | 39.2 | 37.8 | 37.2 | 36.8 | 36.8 | 36.8 | 36.8 | 36.0 |
Antibiotic therapy | A | B | B | C | C | C | D | D | D | D |
Influenza A antigen | Negative | |||||||||
Influenza B antigen | Positive | |||||||||
Urine RBC/HPF | 30-49 | 30-49 | 20-29 | |||||||
Urine WBC/HPF | 10-19 | 30-49 | 30-49 | |||||||
Urine culture | NG | NG | NG | |||||||
Blood culture | NG | NG | NG | |||||||
Sputum culture | Yeast | |||||||||
Blood WBC count/μL | 16,100 | 14,500 | 19,600 | 24,500 | 34,500 | 31,100 | 18,100 | 17,300 | 19,200 | 9,000 |
Blood platelet count/μL | 449,000 | 435,000 | 495,000 | 600,000 | 214,000 | 173,000 | 99,000 | 89,000 | 41,000 | 55,000 |
Blood hemogram (g/dL) | 12.4 | 10.8 | 9.9 | 8.1 | 6.9 | 6.1 | 8.6 | 8.8 | 8.8 | 9.3 |
CRP (< 5 mg/L) | 238.0 | 319.1 | 296.0 | 315.7 | 183.6 | 175.0 | 34.7 | 22.8 | 72.6 | 62.7 |
Procalcitonin (< 0.05 ng/mL) | 7.23 | 24.22 | 1.14 | |||||||
BUN (6-20 mg/dL) | 13 | 61 | 117 | 63 | 54 | 162 | 43 | 93 | ||
Creatinine (0.57-1.11 mg/dL) | 0.77 | 0.82 | 4.52 | 8.72 | 4.01 | 1.46 | 5.09 | 1.28 | 2.16 | |
AST (5-34 U/L) | 34 | 53 | ||||||||
ALT (2-40 U/L) | 37 | 69 | ||||||||
CMV-PCR | Positive | Positive | ||||||||
Aspergillus Ag (< 0.5 index) | 0.32 | 6.37 |
ICU: Intensive Care Unit; Antibiotic A: Cefuroxime (for 4 days); Antibiotic B: Moxifloxacin (for 5 days); Antibiotic C: Piperacillin-tazobactam (for 16 days); Antibiotic D: Piperacillin (for 18 days); RBC: Red Blood Cell; WBC: White Blood Cell; HPF: High Power Field; NG: No Growth; CRP: C-Reactive Protein; BUN: Blood Urea Nitrogen; AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase; CMV-PCR: Cytomegalovirus-Polymerase Chain Reaction.